Pfizer Inc said on Thursday it plans to donate six million therapeutic doses of its Covid-19 drug to a global non-governmental fund for low- and middle-income countries to help address disparities in the fight against the coronavirus. around the world.
The company said doses of baxlovid will be made available through the Fund (Covid-19 Response Mechanism) to 132 low- and middle-income countries this year, subject to approval from local regulators.
Although Baxlovid is widely available in many rich countries, access is very limited in poor countries. Pfizer says the supply agreement is part of its strategy to promote equitable access to oral Covid treatment.
The company has signed agreements with several non-brand drug manufacturers to produce the treatment at a lower cost for developing countries.
“This agreement with the Foundation is an important step that will promote equitable access (to the drug) for high-risk patients in low- and middle-income countries,” the company’s CEO Albert Borla said in a statement.